: FDA advisers narrowly back accelerated approval of Sarepta gene therapy
FDA advisers vote 8-6 Friday to recommend the agency grant accelerated approval to Sarepta Therapeutics Inc.’s gene therapy for Duchenne muscular dystrophy.
Computers Tech Games Crypto Music and More